HuGE Literature Finder
Records
1
-
5
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer. Scientific reports 2022 02 12 (1): 2167. Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Korphaisarn Krittiya, Leelayuwatanakul Nophol, Pornpatrananrak Nopporn, Poungvarin Naravat, Chantranuwat Poonchavist, Shuangshoti Shanop, Aporntewan Chatchawit, Chintanapakdee Wariya, Sriuranpong Virote, Vinayanuwattikun Chani |
Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases. JAMA network open 2020 Aug 3 (8): e209077. Li Yang-Si, Zheng Mei-Mei, Jiang Ben-Yuan, Tu Hai-Yan, Yang Jin-Ji, Zhang Xu-Chao, Wu Yi-Lo |
Concomitant Genetic Alterations are Associated with Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated with Tyrosine Kinase Inhibitors. Translational oncology 2019 Aug 12 (11): 1425-1431. Chang Shih-Chieh, Lai Yi-Chun, Chang Cheng-Yu, Huang Li-Kuo, Chen Shu-Jen, Tan Kien Thiam, Yu Pei-Ning, Lai Jiun |
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Sep 11 (9): 1493-502. Schrock Alexa B, Frampton Garrett M, Suh James, Chalmers Zachary R, Rosenzweig Mark, Erlich Rachel L, Halmos Balazs, Goldman Jonathan, Forde Patrick, Leuenberger Kurt, Peled Nir, Kalemkerian Gregory P, Ross Jeffrey S, Stephens Philip J, Miller Vincent A, Ali Siraj M, Ou Sai-Hong Ignati |
Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 32-7. Ma Hongxia, Chen Jiaping, Pan Shiyang, Dai Juncheng, Jin Guangfu, Hu Zhibin, Shen Hongbing, Shu Yongqi |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: